• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Beta-aescin in the treatment of chronic venous insufficiency].

作者信息

Gerová Z, Stvrtinová V, Sefránek V, Illek B

机构信息

Centrum klinickej farmakológie VULB, Bratislava.

出版信息

Cas Lek Cesk. 1991 Jan 4;130(1):15-9.

PMID:2004385
Abstract

In 15 patients with primary or secondary chronic venous insufficiency (CHVI) the authors evaluated the action of three weeks' treatment with beta-aescin (Yellon caps). The regression of clinical symptoms of CHVI (sensation of "heavy" and "tired" legs, swollen ankles, nocturnal cramps was complete in five patients, partial or slight in seven patients, and none in three patients (with secondary venous insufficiency associated with thrombosis of the deep venous system). Undesirable effects of the agent were not revealed by common screening tests. No change of the basic parameters of haemostasis occurred. The haemodynamic action on the venous and capillary circulation of the lower extremities was evaluated by the method of venous occlusion plethysmography. Already after the first week of treatment a significant drop of capillary filtration to 74% of the original mean value before treatment occurred (0.265 +/- 0.084 ml/100 ml tissue). After the second and third week of treatment the values of capillary filtration decreased on average to 66% of the original mean value. The venous capacity (before treatment on average 3.5 +/- 0.9 ml/100 ml tissue) and venous drainage (before treatment on average 24.5 +/- 13.5 ml min/100 ml) did not change significantly during treatment.

摘要

相似文献

1
[Beta-aescin in the treatment of chronic venous insufficiency].
Cas Lek Cesk. 1991 Jan 4;130(1):15-9.
2
[Effects of horse-chestnut seed extract on transcapillary filtration in chronic venous insufficiency].[七叶树籽提取物对慢性静脉功能不全时跨毛细血管滤过的影响]
Dtsch Med Wochenschr. 1986 Aug 29;111(35):1321-9. doi: 10.1055/s-2008-1068628.
3
Efficacy and safety of a Butcher's broom preparation (Ruscus aculeatus L. extract) compared to placebo in patients suffering from chronic venous insufficiency.一种假叶树制剂(刺叶假叶树提取物)与安慰剂相比,对慢性静脉功能不全患者的疗效和安全性。
Arzneimittelforschung. 2002;52(4):243-50. doi: 10.1055/s-0031-1299887.
4
Rapid relief of signs/symptoms in chronic venous microangiopathy with pycnogenol: a prospective, controlled study.
Angiology. 2006 Oct-Nov;57(5):569-76. doi: 10.1177/0003319706291392.
5
[Effect of 0-(beta-hydroxyethyl)-rutoside (Venoruton) on symptomatic venous insufficiency in the lower limbs].
Ugeskr Laeger. 1992 Sep 14;154(38):2561-3.
6
Clinical and capillaroscopic evaluation in the treatment of chronic venous insufficiency with Ruscus aculeatus, hesperidin methylchalcone and ascorbic acid in venous insufficiency treatment of ambulatory patients.在门诊患者静脉功能不全治疗中,使用刺路路通、橙皮苷甲基查耳酮和抗坏血酸治疗慢性静脉功能不全的临床及毛细血管镜评估
Int Angiol. 2007 Dec;26(4):378-84.
7
Treatment of edema and increased capillary filtration in venous hypertension with total triterpenic fraction of Centella asiatica: a clinical, prospective, placebo-controlled, randomized, dose-ranging trial.积雪草总三萜部分治疗静脉高压中的水肿和毛细血管滤过增加:一项临床、前瞻性、安慰剂对照、随机、剂量范围试验。
Angiology. 2001 Oct;52 Suppl 2:S55-9.
8
[Clinical and capillaroscopic evaluation of chronic uncomplicated venous insufficiency with procyanidins extracted from vitis vinifera].[从葡萄中提取的原花青素对慢性单纯性静脉功能不全的临床及毛细血管镜评估]
Minerva Cardioangiol. 1999 Jan-Feb;47(1-2):39-46.
9
[Evaluation of clinical efficacy of a venotonic drug: lessons of a therapeutic trial with hemisynthesis diosmin in "heavy legs syndrome"].[一种静脉张力调节药物的临床疗效评估:半合成地奥司明治疗“下肢沉重综合征”的治疗试验经验]
J Mal Vasc. 1998 Apr;23(2):106-12.
10
Capillary filtration in venous hypertension: evaluation with the vacuum suction chamber device and strain-gauge plethysmography.
Angiology. 2001 Oct;52 Suppl 2:S39-43.